NEU 2.59% $13.56 neuren pharmaceuticals limited

And just to address the potential flaw in this analysis. - one...

  1. 2,428 Posts.
    lightbulb Created with Sketch. 780
    And just to address the potential flaw in this analysis. - one reason it probably trades at a comparably low PE is the amount of our revenue that is made of 'one-off' milestone payments. I think this is flawed logic however, given we look set to continue to receive these milestones in the next few years, bridging the gap between US Rett's/trof revenue and all the other potential sources of revenue growth we can expect.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.56
Change
-0.360(2.59%)
Mkt cap ! $1.733B
Open High Low Value Volume
$13.94 $13.96 $13.50 $6.421M 470.4K

Buyers (Bids)

No. Vol. Price($)
2 1643 $13.54
 

Sellers (Offers)

Price($) Vol. No.
$13.61 3100 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.